ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Invesco Income Growth Trust Plc

Invesco Income Growth Trust Plc (IVI)

278.00
0.00
(0.00%)
Cerrado 05 Febrero 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
278.00
Postura de Compra
274.00
Postura de Venta
282.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
278.00
Precio de Apertura
-
Hora
(O)
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

IVI Últimas noticias

Invesco Income Growth Trust Plc - Net Asset Value(s)

Invesco Income Growth Trust Plc - Net Asset Value(s) PR Newswire London, April 27 NET ASSET VALUE BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC 5493003YBY59H9EJLJ16 The unaudited net asset...

Invesco Inc Grth Tst Net Asset Value(s)

NET ASSET VALUE BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC 5493003YBY59H9EJLJ16 The unaudited net asset values for BlackRock Income and Growth Investment Trust PLC at close of business on...

Invesco Inc Grth Tst Statement re Scale Back of Excess Applications

Invesco Income Growth Trust plc (the "Company" or "IIGT") Scale back of Excess Applications As outlined in the Result of Elections announcement made on 21 April 2021, Excess...

Invesco Income Growth Trust Plc - Statement re Scale Back of Excess Applications

Invesco Income Growth Trust Plc - Statement re Scale Back of Excess Applications PR Newswire London, April 23 Invesco Income Growth Trust plc (the “Company” or “IIGT”) Scale back of Excess...

Invesco Inc Grth Tst Statement re Scheme Entitlements

Invesco Income Growth Trust plc (the "Company" or "IIGT") Scheme Entitlements Following the passing of the special resolutions put forward at the Company's First General...

Invesco Income Growth Trust Plc - Statement re Scheme Entitlements

Invesco Income Growth Trust Plc - Statement re Scheme Entitlements PR Newswire London, April 23 Invesco Income Growth Trust plc (the “Company” or “IIGT”) Scheme Entitlements Following the...

Invesco Income Growth Trust Plc - Result of Second General Meeting

Invesco Income Growth Trust Plc - Result of Second General Meeting PR Newswire London, April 23 Invesco Income Growth Trust Plc – Result of Meeting Invesco Income Growth Trust plc (the...

Invesco Inc Grth Tst Result of Second General Meeting

Invesco Income Growth Trust Plc - Result of Meeting Invesco Income Growth Trust plc (the "Company") Results of Second General Meeting 23 April 2021 The Board is pleased to announce that...

Invesco Inc Grth Tst Results of Elections

Invesco Income Growth Trust plc (the "Company") Results of Elections The Company received the following elections (including deemed elections) in connection with the Scheme: * Rollover...

Invesco Income Growth Trust Plc - Results of Elections

Invesco Income Growth Trust Plc - Results of Elections PR Newswire London, April 21 Invesco Income Growth Trust plc (the “Company”) Results of Elections The Company received the following...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

IVI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Invesco Income Growth?
El precio actual de las acciones de Invesco Income Growth es 278.00p
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Invesco Income Growth?
Invesco Income Growth ha negociado en un rango de 0.00p a 0.00p durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 69.50
(0.00%)
1.71k
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 69.50
(0.00%)
1.71k
STXShield Therapeutics Plc
2.85p
(0.00%)
150k
0RIHAlphabet Inc
US$ 205.30
(0.00%)
12.46k
0HD6Alphabet Inc
US$ 207.20
(0.00%)
8.62k
0HCIAlibaba Group Holding Ltd
US$ 103.70
(0.00%)
7.88k
0R24Intel Corp
US$ 19.575
(0.00%)
6.79k
DJPele DJPele 3 minutos hace
Much appreciated Muee! Although I did trust your initial post, it does help seeing it's full contents.
NWBO
CaptainObvious CaptainObvious 7 minutos hace
Something is, that's for sure
NWBO
zino zino 9 minutos hace
I agree...if we get the right Quant Merger this will explode and could turn into a
potential Nasdaq uplisting...Just look at Rgti and its run Quant related and they are raising money so easily...just raised 15O Million ...was a penny stock few months back
GCAN
pgsd pgsd 12 minutos hace
Typical for anything related to DCVax lol

It is included in the list of Proposed 24-25 HC Drugs:

In the alphabetic order from the list it is listed as 'Brain cancer vaccine' which is then crossed out and Murcidencel is added...

https://investorshub.advfn
NWBO
muee88 muee88 14 minutos hace
Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.
NWBO
TurboMountain96 TurboMountain96 14 minutos hace
Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move
ELTP
RichieBoy RichieBoy 15 minutos hace
Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp
AFFU
OnTrack444 OnTrack444 16 minutos hace

Is this your newest made pump account with a 122 followers on X?   😂   Total comedy 🎭 

How much do they pay you to pump bloated pigs because you cer
HMBL
muee88 muee88 19 minutos hace
Unfortunately, I don’t know how to upload a screenshot to this antiquated website —it shouldn’t be this difficult. I can assure you I’m not lying. Also, an email can be faked too so I’m not really sure what a screenshot would tell you.

However, here’s essentially the full text of the
NWBO
123tom 123tom 22 minutos hace
Steve, what you're saying about AVXL price movement not holding the support levels you'd expect... that's something I've watched AVXL do for 14 years. It's what I call the "bleeding down game". I always expect to see lower lows than we ought to see. Even in bullish upwave patterns.... the seller
AVXL
muee88 muee88 25 minutos hace
You need to click the tap entitled “Proposed 24-25 HC drugs.” On my phone, the tab I’m talking about is shown across the top of the website.
NWBO
skitahoe skitahoe 27 minutos hace
When I use your link I get a list of their hospitals, not drugs, am I doing something wrong, or is there a problem with the link.

Thanks,

Gary
NWBO
roadkilll roadkilll 32 minutos hace
Why central banks’ hunger for gold shows ‘no sign of being quelled’ this year
Published: Feb. 5, 2025

Central banks, as well as exchange-traded-fund investors, are likely to drive gold demand this year, with economic uncertainty supporting gold’s role as a risk hedge, the Worl
IAG
demonsmith demonsmith 32 minutos hace
There working on it noting going to happen intell after shareholder metting
TWOH
roadkilll roadkilll 36 minutos hace
Tesla hasn't paid taxes in 3 years
200 P/E
5.5 PEG
$7500 taxpayer from taxpayers to anyone buying a new Tesla
$4000 taxpayer funded payment anyone buying a used Tesla to keep the flow going
30% taxpayer funding to anyone that instals a home battery unit ($3000 if y
TSLA
bluebird50 bluebird50 37 minutos hace
I had a 50 share marker on this and sold it first thing Monday morning.... 

Not feeling good here.... 
pharmas have huge upswings with steady declines!!!  

Time it ladies and gentlemen! 
TNXP
Seminole Red Seminole Red 37 minutos hace
LOLOL
DJPele DJPele 38 minutos hace
Muee, apologies for being persistent, but can you provide a screenshot of the email from the MHRA?
NWBO
muee88 muee88 45 minutos hace
I asked ChatGPT what it meant:

Me: Does Murcidencel being on this list imply that this drug is going to be approved for a marketing authorization?

ChatGPT:

No, the inclusion of Mircidencel on the NHS Proposed 24-25 High-Cost Drugs List does not necessaril
NWBO
muee88 muee88 60 minutos hace
What does Murcidencel being included on this list of “High cost drugs - proposed list for 2024/25” mean?

https://www.england.nhs.uk/wp-content/uploads/2023/12/23-25NHSPS-amendment-consultation-annex.xlsx
NWBO
Werbe Werbe 1 hora hace
Let's get a pr about future intentions, how we make this a $50 m cap company.  I think we can achieve that at least.
ATWT
Seminole Red Seminole Red 1 hora hace
100 feet in difference is only 33 yards, thats pretty close for two vehicles in the air
DocLee DocLee 1 hora hace
HI, DH. Sorry, I don't know whether anybody has contacted either NWBO or the MHRA but you could do it yourself. That would be a much easier option than trawling through tens (or even hundreds) of thousands of messages on this board that have been posted since the MHRA started its assessments. Bes
NWBO
chereb19 chereb19 1 hora hace
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL

Su Consulta Reciente